Loading…

Guardant Health agreed to acquire Bellwether Bio, a private company focused on epigenomic research for early cancer detection, for an undisclosed sum.
“We are excited to welcome the Bellwether team and believe they will enhance our product pipeline as we seek to expand precision oncology to earlier stages of disease.”mddionline.com
Summarized from public sources; check the original articles before acting on it.